Zain Khalpey/LinkedIn
Dec 19, 2025, 09:24
Zain Khalpey on A New Study Linking Low-dose Aspirin to Reduced Cancer Spread
Zain Khalpey, Adjunct Assistant Professor of Surgery at Columbia University Irving Medical Center, shared on LinkedIn:
”A paper in The New England Journal of Medicine outlines a mechanism by which low-dose aspirin may reduce cancer spread, particularly in colorectal cancer and in individuals with certain mutations or CHIP.
By lowering platelet activation and thromboxane A2 signaling, aspirin helps release T cells from immune suppression and supports antimetastatic immunity.
Follow Zain Khalpey for more on Ai and Healthcare.”
Read the full article in NEJM.
Article: Understanding How Aspirin Prevents Metastasis
Authors: Ruth E. Langley, John Burn
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke